Search for: "johnson" Results 81 - 100 of 28,086
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Nov 2012, 2:32 am by Paul Caron
Johnson (Texas), Tax Reform and the Presidential Election, 137 Tax Notes 676 (Nov. 5, 2012): Johnson describes the tax plan of Republican presidential nominee Mitt Romney as aggressively promising tax cuts for the richest taxpayers. [read post]
5 Nov 2012, 2:32 am by Paul Caron
Johnson (Texas), Tax Reform and the Presidential Election, 137 Tax Notes 676 (Nov. 5, 2012): Johnson describes the tax plan of Republican presidential nominee Mitt Romney as aggressively promising tax cuts for the richest taxpayers. [read post]
25 Jan 2013, 1:20 pm
New records have come to light in the face of impending trials regarding Johnson & Johnson's metal-on-metal hip replacements. [read post]
17 Sep 2010, 2:54 am by By CHRIS V. NICHOLSON
Johnson & Johnson, the U.S. health products company, said Friday that it was in advanced talks to offer for the 82 percent of Crucell, a Dutch biopharmaceutical firm, that it does not already own, in what would be a 1.75 billion euro deal. [read post]
9 Feb 2011, 6:22 am by By CHRIS V. NICHOLSON
Shareholders of the Dutch biotechnology company Crucell approved changes to its bylaws and the makeup of its supervisory board, moves that will pave the way for Johnson & Johnson's $2.4 billion takeover. [read post]
23 Dec 2013, 5:43 pm by By MICHAEL J. DE LA MERCED
The Carlyle Group is in exclusive talks to buy Johnson & Johnson's blood-testing unit, in what could lead to a transaction worth about $4 billion, a person briefed on the matter said on Monday. [read post]
20 Jan 2012, 11:57 am
Risperdal is not a cheap drug and has earned Johnson & Johnson close to a billion in profit. [read post]
17 Aug 2019, 6:51 am by Throneberry Law Group
Continue reading The post Federal Evidentiary Hearings in Johnson & Johnson Asbestos Cancer Lawsuits appeared first on Asbestos & Mesothelioma Law Blog. [read post]
11 Mar 2013, 11:54 am by Curt Cutting
As reported in the New York Times, a jury in Los Angeles declined to award punitive damages against Johnson & Johnson in the first of many trials involving an allegedly defective artificial hip made by Johnson & Johnson's DePuy orthopedics unit. [read post]
28 Mar 2016, 1:33 pm by Orlando Personal Injury Attorney
A federal jury awarded a $502 million verdict to five recipients of Johnson & Johnson DePuy hip implants on Thursday, at the conclusion of a trial that accused Johnson & Johnson of covering up known flaws in its Pinnacle artificial hip line. [read post]
28 Mar 2016, 1:33 pm by Orlando Personal Injury Attorney
A federal jury awarded a $502 million verdict to five recipients of Johnson & Johnson DePuy hip implants on Thursday, at the conclusion of a trial that accused Johnson & Johnson of covering up known flaws in its Pinnacle artificial hip line. [read post]
18 Aug 2019, 12:21 pm by Paul Cannon
Company officials admit […] The post Johnson & Johnson Faces Criminal Probe Over Talc-Asbestos Link appeared first on . [read post]
13 Apr 2019, 8:16 am by Throneberry Law Group
Continue reading The post Johnson & Johnson Settles Trio of Talcum Powder Asbestos Lawsuits appeared first on Asbestos & Mesothelioma Law Blog. [read post]
20 Dec 2016, 6:32 am by Alex Berry, contributor
Axiom adds to its roster of pharmaceutical clients and signs up Johnson & Johnson for a five-year term [read post]
24 Apr 2018, 9:29 am
BEAUMONT – Johnson & Johnson and its subsidiary, Ethicon, have been hit with a vaginal mesh lawsuit. [read post]
6 Mar 2017, 7:04 am by Jonathan Rosenfeld
Johnson & Johnson is currently facing a flurry of lawsuits on multiple drugs, devices and over the counter products, but the mounting Xarelto litigation could prove to top its current legal battles, with the first bellwether trial to be heard in March of this year. [read post]
6 Mar 2017, 7:04 am by Jonathan Rosenfeld
Johnson & Johnson is currently facing a flurry of lawsuits on multiple drugs, devices and over the counter products, but the mounting Xarelto litigation could prove to top its current legal battles, with the first bellwether trial to be heard in March of this year. [read post]
4 Feb 2014, 8:00 am by Pete Strom
Louisiana Court Overturns $258 Million Penalty Against J&J for Risperdal Marketing On Tuesday, January 28th, pharmaceutical giant Johnson & Johnson won an appeal in Louisiana Supreme Court to overturn a $258 million penalty for marketing practices associated with its antipsychotic drug, Risperdal. [read post]
23 Aug 2017, 7:51 am by Orlando Personal Injury Attorney
On Monday, August 21, 2017, after a month-long trial in Los Angeles Superior Court, an L.A. jury has awarded a landmark judgement in the lawsuit against pharmaceutical giant Johnson & Johnson in the amount of $417 million, marking the largest settlement to date in a series of talcum powder lawsuits against the company. [read post]